title: Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis.
authors.affiliation: Rockefeller University Hospital, New York, New York 10021, USA.
authors.forename: R G
authors.initials: RG
authors.lastname: Crystal
authors.forename: A
authors.initials: A
authors.lastname: Mastrangeli
authors.forename: A
authors.initials: A
authors.lastname: Sanders
authors.forename: J
authors.initials: J
authors.lastname: Cooke
authors.forename: T
authors.initials: T
authors.lastname: King
authors.forename: F
authors.initials: F
authors.lastname: Gilbert
authors.forename: C
authors.initials: C
authors.lastname: Henschke
authors.forename: W
authors.initials: W
authors.lastname: Pascal
authors.forename: J
authors.initials: J
authors.lastname: Herena
authors.forename: B G
authors.initials: BG
authors.lastname: Harvey
mesh_terms: D000256:Adenoviridae / Q000235:genetics* / Q000502:physiology; D000293:Adolescent; D000328:Adult; D002985:Clinical Protocols; D002986:Clinical Trials as Topic; D003550:Cystic Fibrosis / Q000235:genetics / Q000503:physiopathology / Q000628:therapy*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics*; D018076:DNA, Complementary / Q000008:administration & dosage / Q000235:genetics; D005260:Female; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000009:adverse effects; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000235:genetics; D014779:Virus Replication
chemical_list: C505032:CFTR protein, human; D018076:DNA, Complementary; D011994:Recombinant Proteins; D019005:Cystic Fibrosis Transmembrane Conductance Regulator